Oppenheimer raised the firm’s price target on Zurn Elkay Water (ZWS) to $52 from $48 and keeps an Outperform rating on the shares after hosting investor meetings with CFO Dave Pauli and Director of FP&A Bryan Wendlandt, with Q&A focused on demand trends across end markets, relative project visibility, continued/robust growth of the Elkay drinking water platform, and the team’s M&A strategy. The firm came away highly confident in Zurn Elkay’s ability to meet near-term estimates and sustain core momentum into 2026. Combining that setup with significant dry powder, Oppenheimer likes Zurn’s prospects for continued double-digit earnings/cash flow growth, appreciate the stock’s appeal and investability for an increasingly needle-moving percentage of the market, and see valuation as relatively supportive.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZWS:
